General Information
DRAVP ID DRAVPe01305
Peptide Name HD5[S23R]
Sequence ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR
Sequence Length 32
UniProt ID Q01523
Source Synthetic construct(derived from human alpha defensin(HD5))
Activity Information
Target Organism HSV
Assay Plaque assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target capsid protein gD
Mechanism The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe01305
Linear/Cyclic Cyclic
N-terminal Modification Free
C-terminal Modification Free
Other Modification Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.
Stereochemistry L
Physicochemical Information
Formula C147H251N53O44S6
Absent amino acids DFHKMNPQW
Common amino acids R
Mass 3657.3
Pl 9.22
Basic residues 7
Acidic residues 2
Hydrophobic residues 7
Net charge 5
Boman Index -9501
Hydrophobicity -22.81
Aliphatic Index 64.06
Half Life
Extinction Coefficient cystines 3355
Absorbance 280nm 108.23
Polar residues 16
Literature Information
Literature 1
Title Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.
Pubmed ID 23269800
Reference J Virol. 2013 Mar;87(5):2835-45.
Author Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.